Evidence map›Paper›PMID 29117325›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2017

Risk of Early-Onset Neonatal Group B Streptococcal Disease With Maternal Colonization Worldwide: Systematic Review and Meta-analyses.

Neal J Russell, Anna C Seale, Catherine O'Sullivan, Kirsty Le Doare, Paul T Heath, Joy E Lawn, Linda Bartlett, Clare Cutland, Michael Gravett, Margaret Ip and 7 more

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 97 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
97citing papers in PubMed, 12 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

97 citing papers in PubMed, 12 syntheses or guidelines pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  7. Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  8. Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  9. Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  10. Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  11. Neurodevelopmental Impairment in Children After Group B Streptococcal Disease Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  12. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Pooled it
  13. Trial
  14. Review
  15. Microbiology (Reading, England) · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

37 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 15 institutions in 7 countries.

Neal J RussellMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Anna C SealeMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Catherine O'SullivanPaediatric Infectious Diseases Research Group, St George's, University of London, United Kingdom.
Kirsty Le DoarePaediatric Infectious Diseases Research Group, St George's, University of London, United Kingdom.
Paul T HeathPaediatric Infectious Diseases Research Group, St George's, University of London, United Kingdom.
Joy E LawnMaternal, Adolescent, Reproductive and Child Health Centre, London School of Hygiene & Tropical Medicine, United Kingdom.
Linda BartlettDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Clare CutlandMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Michael GravettGlobal Alliance to Prevent Prematurity and Stillbirth, Seattle, Washington.
Margaret IpDepartment of Microbiology, Faculty of Medicine, Chinese University of Hong Kong.
Shabir A MadhiMedical Research Council: Respiratory and Meningeal Pathogens Research Unit, and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa.
Craig E RubensGlobal Alliance to Prevent Prematurity and Stillbirth, Seattle, Washington.
Samir K SahaBangladesh Institute of Child Health, Dhaka.
Stephanie SchragNational Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Ajoke Sobanjo-Ter MeulenBill & Melinda Gates Foundation, Seattle, Washington.
Johan VekemansWorld Health Organization, Geneva, Switzerland.
Carol J BakerDepartments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas.
St George's, University of London · GBBaylor College of Medicine · USBill & Melinda Gates Foundation · USCenters for Disease Control and Prevention · USChild Health Research Foundation · BDChinese University of Hong Kong · CNGlobal Alliance to Prevent Prematurity and Stillbirth · USHaramaya University · ETJohns Hopkins University · USKing's College London · GBLondon School of Hygiene & Tropical Medicine · GBRespiratory and Meningeal Pathogens Research Unit · ZAUniversity of the Witwatersrand · ZAUniversity of Washington · USWorld Health Organization · CH

Funding

Wellcome Trust 205184/Z/16/ZWorld Health Organization 001
6 · The paper itself

Abstract

backgroundEarly-onset group B streptococcal disease (EOGBS) occurs in neonates (days 0-6) born to pregnant women who are rectovaginally colonized with group B Streptococcus (GBS), but the risk of EOGBS from vertical transmission has not been systematically reviewed. This article, the seventh in a series on the burden of GBS disease, aims to estimate this risk and how it varies with coverage of intrapartum antibiotic prophylaxis (IAP), used to reduce the incidence of EOGBS.

methodsWe conducted systematic reviews (Pubmed/Medline, Embase, Latin American and Caribbean Health Sciences Literature (LILACS), World Health Organization Library Information System [WHOLIS], and Scopus) and sought unpublished data from investigator groups on maternal GBS colonization and neonatal outcomes. We included articles with ≥200 GBS colonized pregnant women that reported IAP coverage. We did meta-analyses to determine pooled estimates of risk of EOGBS, and examined the association in risk of EOGBS with IAP coverage.

resultsWe identified 30 articles including 20328 GBS-colonized pregnant women for inclusion. The risk of EOGBS in settings without an IAP policy was 1.1% (95% confidence interval [CI], .6%-1.5%). As IAP increased, the risk of EOGBS decreased, with a linear association. Based on linear regression, the risk of EOGBS in settings with 80% IAP coverage was predicted to be 0.3% (95% CI, 0-.9).

conclusionsThe risk of EOGBS among GBS-colonized pregnant women, from this first systematic review, is consistent with previous estimates from single studies (1%-2%). Increasing IAP coverage was linearly associated with decreased risk of EOGBS disease.

Indexed as

Streptococcus agalactiaeCarrier StateFemaleGlobal HealthHumansInfant, NewbornInfant, Newborn, DiseasesInfectious Disease Transmission, VerticalPregnancyPregnancy Complications, InfectiousRisk FactorsStreptococcal Infectionsgroup B Streptococcusneonatal sepsisriskStreptococcus agalactiaevertical transmission

Identifiers

PMID29117325
PMCPMC5850448
OpenAlexW2768050546

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.